Biologit
Biologit is an Irish AI company that provides the MLM-AI SaaS platform for AI-powered medical literature monitoring in pharmacovigilance, serving large pharma, CROs, and biotechs across 170+ countries with GxP- and CFR 21 Part 11-compliant screening workflows.
- Company typePrivate
- Founded2019
- HeadquartersDublin, Ireland
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Biologit does
Biologit is an Irish AI company that develops and sells the MLM-AI platform, a SaaS solution purpose-built for medical literature monitoring within pharmacovigilance (PV) workflows. The platform screens scientific literature for suspected adverse events, suspected cases with identifiable patients, and special situations, replacing manual literature review processes used by drug safety teams. Biologit serves large pharmaceutical companies (including members of the top 25 global pharma), contract research organizations (CROs), pharmacovigilance service providers, and emerging biotechs, with claimed active coverage in 170+ countries.
The platform is built on proprietary NLP and machine learning models trained on a broad cross-section of scientific literature, combined with the Biologit Database — a proprietary repository aggregating over 50 million citations from 110,000+ journals across global and regional sources (PubMed, Crossref, DOAJ, SciELO, DialNet, IBECS, LILACS, MEDES), updated daily with deduplication. Core platform capabilities include AI-driven article tagging, automated duplicate detection by ID/DOI/content, machine translation of non-English sources, E2B R2/R3 XML export for ICSR regulatory reporting, configurable monitors, dashboards, audit logs with indefinite retention, and a recently launched Integrations module for external system connectivity. The platform holds certifications or compliance attestations across ISO 27001:2022, FDA CFR 21 Part 11, GxP/GAMP V-Model, EU GDPR, and the EU AI Pact. Biologit also offers Human PV Services and Veterinary PV Services as services modules layered on the platform, expanding the addressable market into end-to-end PV operations and the animal health regulatory segment.
Biologit is a privately held company headquartered in Dublin, Ireland, founded in 2019, with 11–50 employees. The company has raised approximately €2 million in a March 2023 seed-equivalent round led by Enterprise Ireland, in addition to an earlier April 2022 round of approximately $1.1M. Revenue is generated through enterprise SaaS subscriptions sold via a demo-driven, consultative sales motion with quote-based pricing — no public pricing tiers are disclosed. Customer acquisition is supported by content marketing (whitepapers, case studies, resource hub), LinkedIn, YouTube, and direct enterprise sales outreach targeting PV team leaders. Co-founders Dr. Nicole Baker (CEO) and Bruno Ohana, PhD (CTO) lead the company alongside COO Jean Redmond, PhD.
Biologit firmographics
Firmographics- Name
- Biologit
- Legal name
- Biologit
- Website
- https://biologit.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biologit is an Irish AI company that provides the MLM-AI SaaS platform for AI-powered medical literature monitoring in pharmacovigilance, serving large pharma, CROs, and biotechs across 170+ countries with GxP- and CFR 21 Part 11-compliant screening workflows.
- Ownership category
- akta.pro rank
Biologit industry classification
Industry- Product category
- Pharmacovigilance Software
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where Biologit is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
Biologit business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Platform Subscription: Subscription-based SaaS model providing access to the MLM-AI platform for literature monitoring. The platform is described as a complete literature screening solution delivered as a service.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription - pricing not publicly disclosed |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Biologit product offering
Product offeringCore offering
Biologit provides an AI-powered medical literature monitoring platform (MLM-AI) built exclusively for pharmacovigilance. The platform automates screening of global and local scientific literature for suspected adverse events and identifiable patients, performs duplicate detection and machine translation, and generates auditable, GxP-compliant outputs that feed ICSR, signal detection, and aggregate reporting workflows. Two complementary service modules—Human PV Services and Veterinary PV Services—deliver end-to-end pharmacovigilance support on top of the platform.
Product overview
Biologit offers a single unified product—the MLM-AI platform—for AI-powered medical literature monitoring exclusively designed for pharmacovigilance. The core Biologit MLM-AI platform provides automated literature screening with AI-driven adverse event detection, duplicate removal, and full regulatory compliance. Two complementary service modules (Human PV Services and Veterinary PV Services) deliver end-to-end pharmacovigilance support using the platform. Key features include E2B XML export for regulatory reporting, machine translation (Beta) for global literature, an Integrations module for external system connectivity, and analytics Dashboards (Beta). The platform is built on the Biologit Database—a unified scientific repository of 50+ million citations from 110,000+ journals spanning global and local sources.
Differentiator
Problem solved
Functional benefit
Products and services
- Biologit MLM-AI AI-powered medical literature monitoring platform built exclusively for pharmacovigilance. Provides automated screening, duplicate detection, AI tagging for adverse event prediction, and fully GxP-compliant audit trails for literature monitoring workflows. Targeted at enterprise pharma, biotechs, and CROs.
- Human PV Services End-to-end pharmacovigilance support services for human medicinal products including regulatory oversight, QPPV services, signal detection, literature monitoring, ICSR surveillance, aggregate reporting, and compliance/quality support, delivered via the MLM-AI platform.
- Veterinary PV Services Pharmacovigilance services for veterinary medicinal products including scientific literature monitoring, quality systems support, QPPV services, project planning and training. Supports compliance with EU Regulation 2019/6 and FDA CVM requirements.
- Biologit Database Comprehensive scientific literature database integrated into the MLM-AI platform, hosting over 50 million citations and 110,000+ journals from global and regional sources including PubMed, Crossref, DOAJ, SciELO, DialNet, IBECS, LILACS, and MEDES.
Quantifiable outcome
- 50-70% reduction in screening effort
- +3 more outcomes
Companies that use Biologit
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles3 records
Biologit technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
Biologit partnerships and signals
Strategic signalScale indicators6 records
Recent moves7 records
Expansion highlights6 records
Biologit competitors and assessment
Company assessmentDirect peers
- ArisGlobal: ArisGlobal's LifeSphere Safety/MVigilance is a leading pharmacovigilance safety database suite that directly competes with Biologit's MLM-AI platform in PV literature monitoring and case management workflows for pharma and CRO customers.
- EXTEDO: EXTEDO provides pharmacovigilance and regulatory affairs software suites (including literature monitoring modules) to pharma, biotech, and CROs — directly comparable in offering and customer base to Biologit's MLM-AI platform.
- AB-Cube: AB-Cube's SafetyEasy is a dedicated PV literature monitoring and safety workflow tool for pharma and CROs, making it a direct functional competitor to Biologit MLM-AI in ICSR literature screening.
- Instem: Instem's Knowledge Scan product is a literature monitoring solution specifically designed for pharmacovigilance workflows — directly comparable to Biologit MLM-AI in serving PV teams at pharma and CROs.
Broad incumbents
- Veeva Systems: Veeva's Vault Safety platform is part of a broader life sciences CRM and regulatory suite sold enterprise-wide. While not specialized solely in literature monitoring, Vault Safety overlaps with Biologit on PV case processing and aggregate reporting.
- Oracle Health Sciences: Oracle's Argus Safety is one of the most widely deployed PV safety databases globally. While Oracle is a much broader enterprise software player, Argus directly competes in the regulated safety workflow space where Biologit operates.
- IQVIA: IQVIA is a global CRO and life sciences technology provider with AI-enabled drug safety and PV services. While broader than Biologit, IQVIA competes for the same enterprise PV technology and managed services budget.
Emerging players
- Elsevier (PharmaPendium / Embase): Elsevier provides large-scale scientific literature databases (Embase) and drug safety data resources (PharmaPendium) used in pharmacovigilance. While traditionally a data vendor rather than a PV workflow platform, it increasingly competes at the data layer Biologit relies on.
- Cube Tech: Cube Tech provides pharmacovigilance case processing and safety database technology to small and mid-size pharma — overlapping with Biologit's biotech and mid-size pharma target segment.
Others
- ProQuest (Clarivate): ProQuest provides aggregated scientific literature databases and research tools that support PV literature workflows. It is adjacent to Biologit as a content/enabling layer rather than a direct PV workflow competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Biologit social profiles
Digital presenceBiologit compliance and trust
Trust signalCompliance5 records
Biologit financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biologit leadership team
Management profileNumber of profiles
Profiles4 records
Biologit funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biologit M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biologit
What does Biologit do?
Biologit provides an AI-powered medical literature monitoring platform (MLM-AI) built exclusively for pharmacovigilance. The platform automates screening of global and local scientific literature for suspected adverse events and identifiable patients, performs duplicate detection and machine translation, and generates auditable, GxP-compliant outputs that feed ICSR, signal detection, and aggregate reporting workflows. Two complementary service modules—Human PV Services and Veterinary PV Services—deliver end-to-end pharmacovigilance support on top of the platform.
Is Biologit a public or private company?
Biologit is a private company. It is classified as venture growth investor backed and is currently operating.
When was Biologit founded?
Biologit was founded in 2019. It employs 11 to 50 people.
Where is Biologit based?
Biologit is headquartered in Dublin, Ireland, in the Europe region.
How does Biologit make money?
One revenue line is on record: saaS Platform Subscription.
Who are Biologit's main competitors?
Direct peers on record are ArisGlobal, EXTEDO, AB-Cube and Instem. Broad incumbents are Veeva Systems, Oracle Health Sciences and IQVIA. Emerging players are Elsevier (PharmaPendium / Embase) and Cube Tech. ProQuest (Clarivate) is listed as an others.
Does Biologit have an API?
No public API is recorded for Biologit.
What industry is Biologit in?
Biologit's product category is Pharmacovigilance Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 541714 and its SIC code is 7372.